DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Phylloquinone is an investigational drug.
There have been 5 clinical trials for Phylloquinone. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2000.
The most common disease conditions in clinical trials are Osteoporosis, Calcinosis, and Kidney Diseases. The leading clinical trial sponsors are Dr. Rachel Holden, Kingston General Hospital, and Guy's and St Thomas' NHS Foundation Trust.
Recent Clinical Trials for Phylloquinone
|Vitamin K1 to Slow Progression of Vascular Calcification in HD Patients||RWTH Aachen University||Phase 3|
|Vitamin K to Attenuate Coronary Artery Calcification in Hemodialysis Patients||Kingston General Hospital||Phase 2|
|Vitamin K to Attenuate Coronary Artery Calcification in Hemodialysis Patients||Dr. Rachel Holden||Phase 2|